HIMS Hims & Hers Health Earnings and EPS analysis

Relative Growth: Rel. Growth: 35

Relative Strength: Rel. Strength: 44

Relative Valuation: Rel. Valuation: 18

Relative Profitability: Rel. Profitability: 34

EPS in 2026 (TTM): -$0.05

Last Report Period Date: Mar 31, 2026

As of June 2026, HIMS's trailing twelve months (TTM) EPS stands at -$0.05, according to the latest financial reports. Hims & Hers Health's EPS for 2025 came in at $0.57, marking a decrease from $0.58 in 2024. HIMS reported an EPS of -$0.4 for the quarterly report ending on Mar 31, 2026.

HIMS earnings history

Historical annual and quarterly earnings per share (EPS) data for Hims & Hers Health

EPS (TTM)

-$0.05

EPS Growth YoY (Quarterly)

-281.8%

EPS (Quarterly)

-$0.4

EPS Growth (Quarterly)

-544.4%

For 2025, Hims & Hers Health's EPS was $0.57, a decrease of 1.7% from $0.58 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was -$0.4, marking a 281.8% decrease from the same quarter last year. HIMS's TTM EPS stands at -$0.05 as of March 2026. Hims & Hers Health's EPS for 2024 stood at $0.58, a 627.3% increase from 2023.

HIMS earnings chart

HIMS EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-281.8%

EPS growth YoY

-1.7%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Hims & Hers Health has recorded a decrease in EPS of 281.8% over the last 12 months (YoY, quarterly).

HIMS Earnings Waterfall

Breakdown of revenue, profit and net income for Hims & Hers Health

HIMS Earnings vs Peers

What are the earnings of HIMS compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
NBIX Neurocrine Biosciences Inc	24.42	41.5%	44%	1.9%
NVAX Novavax Inc	N/A	321.1%	N/A	N/A
NVCR NovoCure Ltd	N/A	21.8%	N/A	N/A
HIMS Hims & Hers Health Inc	N/A	-1.7%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.